Elizabeth E Reed's Net Worth
$2.32 Million
Who is Elizabeth E Reed?
Elizabeth E Reed has an estimated net worth of $2.32 Million. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., Celladon Corp, and ANADYS PHARMACEUTICALS INC.
SEC CIK
Elizabeth E Reed's CIK is 0001283303
Past Insider Trading and Trends
2020 was Elizabeth E Reed's most active year for acquiring shares with 7 total transactions. Elizabeth E Reed's most active month to acquire stocks was the month of December. 2006 was Elizabeth E Reed's most active year for disposing of shares, totalling 14 transactions. Elizabeth E Reed's most active month to dispose stocks was the month of December. 2006 saw Elizabeth E Reed paying a total of $13,275.00 for 49,500 shares, this is the most they've acquired in one year. In 2022 Elizabeth E Reed cashed out on 10,550 shares for a total of $272,138.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Travere Therapeutics, Inc. (TVTX) Snapshot price: $10.98
SVP, GC & CORPORATE SECRETARY
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.10% | 2.36K |
$11.52 | -$50,538.24 | 78.63K |
Scheduled
|
Sep 5 - Sep 9
| ||
Form 4
| +36.11% | 20.24K |
$8.71 | -$41,495.32 | 76.27K |
Jan 31 - Feb 1
| |||
Form 4
| -3.55% | -2.06K |
$8.96 | -$18,475.52 | 56.03K |
Jan 23
| |||
Form 4
| +2.62% | 1.49K |
$14.71 | -$26,698.65 | 58.1K |
Aug 31 - Sep 5
| |||
Form 4
| -1.44% | -825.00 |
$16.59 | -$13,686.75 | 56.61K |
May 10
| |||
Form 4
| +44.40% | 17.66K |
$22.25 | -$57,627.50 | 57.44K |
Scheduled
|
Jan 31 - Feb 1
| ||
Form 4
| -4.93% | -2.06K |
$21.50 | -$44,333.00 | 39.78K |
Scheduled
|
Jan 24
| ||
Form 4
| -4.45% | -1.95K |
$21.51 | -$41,943.45 | 41.84K |
Scheduled
|
May 10 - May 12
| ||
Form 4
| +24.05% | 8.49K |
$27.40 | -$36,990.00 | 43.79K |
Scheduled
|
Jan 31
| ||
Form 4
| -5.99% | -2.25K |
$24.98 | -$56,205.00 | 35.3K |
Scheduled
|
Jan 24
| ||
Form 4
|
—
|
0
|
$27.40 | -$137,000.00 | 37.55K |
Scheduled
|
Jan 10 - Jan 11
| ||
Form 4
| +8.98% | 3.09K |
$17.12 | -$24,086.01 | 37.55K |
Aug 13 - Aug 17
| |||
Form 4
| -8.62% | -3.25K |
$19.30 | -$62,725.00 | 34.45K |
Scheduled
|
May 11 - May 12
| ||
Form 4
| -10.66% | -4.50K |
$31.50 | -$141,727.50 | 37.7K |
Scheduled
|
Feb 5 - Feb 8
| ||
Form 4
| +11.93% | 4.5K |
—
|
—
| 42.2K |
Feb 3
| |||
Form 4
| -7.77% | -3.17K |
$28.91 | -$91,789.25 | 37.7K |
Scheduled
|
Feb 3
| ||
Form 4
| +4.67% | 1.82K |
$30.75 | -$97,631.25 | 40.88K |
Scheduled
|
Jan 31 - Feb 2
| ||
Form 4
| +62.36% | 15K |
—
|
—
| 39.05K |
Jan 21
| |||
Form 4
| -5.41% | -1.38K |
$26.83 | -$36,918.08 | 24.05K |
Scheduled
|
Jan 5 - Jan 6
| ||
Form 4
| -8.95% | -2.50K |
$23.98 | -$59,950.00 | 25.43K |
Scheduled
|
Nov 16
| ||
Form 4
| +9.83% | 2.5K |
$23.62 | -$59,045.50 | 27.93K |
Scheduled
|
Nov 11 - Nov 13
| ||
Form 4
| -5.57% | -1.50K |
$18.48 | -$27,720.00 | 25.43K |
Scheduled
|
Sep 23
| ||
Form 4
| +5.90% | 1.5K |
$18.59 | -$27,885.00 | 26.93K |
Scheduled
|
Sep 18 - Sep 22
| ||
Form 4
| -5.84% | -1.58K |
$16.37 | -$25,808.48 | 25.43K |
Scheduled
|
May 11 - May 12
| ||
Form 4
| -11.47% | -3.50K |
$15.02 | -$52,570.00 | 27.01K |
Scheduled
|
Mar 10
| ||
Form 4
| +12.96% | 3.5K |
—
|
—
| 30.51K |
Mar 5
| |||
Form 4
| +49.98% | 9K |
—
|
—
| 27.01K |
Jan 31
| |||
Form 4
| -7.69% | -1.50K |
$14.54 | -$21,810.00 | 18.01K |
Scheduled
|
Jan 7 - Jan 8
| ||
Form 4
| -5.11% | -1.05K |
$17.73 | -$18,616.50 | 19.51K |
Scheduled
|
May 14 - May 15
| ||
Form 4
| +41.21% | 6K |
—
|
—
| 20.56K |
May 9
| |||
Form 4
| -10.83% | -1.77K |
$21.44 | -$37,927.30 | 14.56K |
Scheduled
|
Feb 11 - Feb 12
| ||
Form 4
| -8.41% | -1.50K |
$23.96 | -$35,932.50 | 16.33K |
Scheduled
|
Jan 8 - Jan 9
| ||
Form 4
| -21.90% | -5.00K |
$24.03 | -$120,145.93 | 17.83K |
Scheduled
|
Nov 14 - Nov 15
| ||
Form 4
| +28.05% | 5K |
—
|
—
| 22.83K |
Nov 9
| |||
Form 4
| +64.65% | 7K |
—
|
—
| 17.83K |
May 10
| |||
Form 4
| +19.53% | 1.77K |
—
|
—
| 10.83K |
Feb 8
| |||
Form 4
| -9.42% | -942.00 |
$24.04 | -$22,645.68 | 9.06K |
Jan 5
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celladon Corp (EIGR) No price found
VP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANADYS PHARMACEUTICALS INC No price found
SVP, Legal Affairs and GC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
$8.31 | -$16,082.07 | 1.04K |
Scheduled
|
Apr 10
| ||
Form 4
|
—
|
0
|
$6.90 | -$11,835.00 |
0
|
Scheduled
|
Feb 13
| ||
Form 4
|
—
|
0
|
$6.48 | -$10,579.00 | 500 |
Scheduled
|
Jan 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||